Reply to the Comment by Dr. Cure on "Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade"

Nephron. 2020;144(5):253-254. doi: 10.1159/000507861. Epub 2020 Apr 24.

Authors

Luca Perico¹, Ariela Benigni¹, Giuseppe Remuzzi^{2

3}

Affiliations

¹ Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy.
² Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Centro Anna Maria Astori, Science and Technology Park Kilometro Rosso, Bergamo, Italy, giuseppe.remuzzi@marionegri.it.
³ Department of Biomedical and Clinical Sciences, University of Milan, Milan, Italy, giuseppe.remuzzi@marionegri.it.

No abstract available

Publication types

Letter
Comment

MeSH terms

Angiotensin-Converting Enzyme Inhibitors*
Angiotensins*
Betacoronavirus*
COVID-19
Coronavirus Infections
Humans
Nephrologists
Pandemics
Pneumonia, Viral
SARS-CoV-2

Substances

Angiotensin-Converting Enzyme Inhibitors
Angiotensins